✦ LIBER ✦

PMH22 BUDGET IMPACT OF THE USE OF RISPERIDONE LONG ACTING INJECTABLE IN THE GERMAN HEALTH CARE SYSTEM

✍ Scribed by M Gaudig; J Fleischmann; F Püschner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH21 THE COST-EFFECTIVENESS OF RISPERID

✍ J Damen; BMS Heeg; M Lothgren; BA Van Hout 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PMH23 IMPACT OF RISPERIDONE LONG-ACTING

✍ L Beauclair; A Lam; J McCormick; D Luong; F Camacho 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PMH13 COMPARATIVE EFFECTIVENESS STUDY OF

✍ L. Grimaldi-Bensouda; F. Rouillon; L. Abenhaim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH35 COMPARISONS OF MENTAL HEALTH-RELAT

✍ Park, H.; Kim, D.N.; Rascati, K.L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMH11 The Cost-Effectiveness of Risperid

✍ Li, H.; Ren, J.; Yu, X. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB